Buscar
Sophia Genetics SA
SOPHAñadir a la lista de seguimiento
5.350USD
-0.240-4.29%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
384.08MCap. mercado
PérdidaP/E TTM
Más Datos de Sophia Genetics SA Compañía
SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide.
Información de Sophia Genetics SA
Símbolo de cotizaciónSOPH
Nombre de la empresaSOPHiA GENETICS SA
Fecha de salida a bolsaJul 23, 2021
Director ejecutivoCamblong (Jurgi)
Número de empleados423
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 23
DirecciónLa Piece 12
CiudadROLLE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísSwitzerland
Código postalCH-1180
Teléfono41216941060
Sitio Webhttps://www.sophiagenetics.com/
Símbolo de cotizaciónSOPH
Fecha de salida a bolsaJul 23, 2021
Director ejecutivoCamblong (Jurgi)
Ejecutivos de Sophia Genetics SA
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
2.98M
-0.94%
Mr. Ross J Muken
Mr. Ross J Muken
President
President
625.61K
-0.07%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
509.18K
-0.79%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%
Mr. Troy M. Cox
Mr. Troy M. Cox
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
294.96K
+6.69%
Mr. George A. Cardoza
Mr. George A. Cardoza
Chief Financial Officer
Chief Financial Officer
217.28K
+8.85%
Mr. Didier Hirsch
Mr. Didier Hirsch
Non-Executive Independent Director
Non-Executive Independent Director
204.44K
+9.65%
Dr. Philippe Menu, M.D., Ph.D.
Dr. Philippe Menu, M.D., Ph.D.
Chief Medical Officer and Chief Product Officer
Chief Medical Officer and Chief Product Officer
128.68K
-7.77%
Mr. Daan Van Well
Mr. Daan Van Well
Chief Legal and Compliance Officer
Chief Legal and Compliance Officer
--
--
Ms. Manuela Da Silva Valente
Ms. Manuela Da Silva Valente
Chief People Officer
Chief People Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
2.98M
-0.94%
Mr. Ross J Muken
Mr. Ross J Muken
President
President
625.61K
-0.07%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
509.18K
-0.79%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%
Mr. Troy M. Cox
Mr. Troy M. Cox
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
294.96K
+6.69%
Mr. George A. Cardoza
Mr. George A. Cardoza
Chief Financial Officer
Chief Financial Officer
217.28K
+8.85%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Sophia Genetics SA?
Los cinco principales accionistas de Sophia Genetics SA son: Dr. Jurgi Camblong, Ph.D.
¿Cuántas instituciones poseen acciones de Sophia Genetics SA (SOPH)?
A fecha de 2026Q1, 89 instituciones poseen acciones de Sophia Genetics SA, con un valor de mercado combinado de aproximadamente 27.73M, lo que representa el 38.63% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -11894064.00.